Auris Medical Holding Ltd (EARS) - Financial and Strategic SWOT Analysis Review
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Auris Medical Holding Ltd (EARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Auris Medical Holding Ltd (Auris Medical) is a clinical-stage biopharmaceutical company with focus on neurotology and CNS disorders. The companys pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, post-acute inner ear tinnitus, tinnitus, Vertigo, sudden loss of hearing, antipsychotic-induced weight gain and somnolence. It has research collaboration and licensing agreements with research institutions such as Kings College London, Pharmaceutical and Biotechnology companies including Xigen and Inserm. Auris Medical is headquartered in Hamilton, Bermuda.
Auris Medical Holding Ltd Key Recent Developments
Sep 17,2020: Auris Medical provides business update and reports first half 2020 financial results
Apr 16,2020: Auris Medical provides business update and reports second half and full year 2019 financial results
Dec 30,2019: Auris Medical announces formation of new subsidiary for development projects in tinnitus and hearing loss
Sep 04,2019: Auris Medical announces appointment of new Chief Financial Officer
Aug 15,2019: Auris Medical provides business update and reports first half 2019 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Auris Medical Holding Ltd (Auris Medical) is a clinical-stage biopharmaceutical company with focus on neurotology and CNS disorders. The companys pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, post-acute inner ear tinnitus, tinnitus, Vertigo, sudden loss of hearing, antipsychotic-induced weight gain and somnolence. It has research collaboration and licensing agreements with research institutions such as Kings College London, Pharmaceutical and Biotechnology companies including Xigen and Inserm. Auris Medical is headquartered in Hamilton, Bermuda.
Auris Medical Holding Ltd Key Recent Developments
Sep 17,2020: Auris Medical provides business update and reports first half 2020 financial results
Apr 16,2020: Auris Medical provides business update and reports second half and full year 2019 financial results
Dec 30,2019: Auris Medical announces formation of new subsidiary for development projects in tinnitus and hearing loss
Sep 04,2019: Auris Medical announces appointment of new Chief Financial Officer
Aug 15,2019: Auris Medical provides business update and reports first half 2019 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
TABLE OF CONTENTS
Section 1 - About the Company
Auris Medical Holding Ltd - Key Facts
Auris Medical Holding Ltd - Key Employees
Auris Medical Holding Ltd - Key Employee Biographies
Auris Medical Holding Ltd - Major Products and Services
Auris Medical Holding Ltd - History
Auris Medical Holding Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Auris Medical Holding Ltd - Business Description
R&D Overview
Auris Medical Holding Ltd - Corporate Strategy
Auris Medical Holding Ltd - SWOT Analysis
SWOT Analysis - Overview
Auris Medical Holding Ltd - Strengths
Auris Medical Holding Ltd - Weaknesses
Auris Medical Holding Ltd - Opportunities
Auris Medical Holding Ltd - Threats
Auris Medical Holding Ltd - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Auris Medical Holding Ltd, Recent Deals Summary
Section 5 Companys Recent Developments
Sep 17, 2020: Auris Medical provides business update and reports first half 2020 financial results
Apr 16, 2020: Auris Medical provides business update and reports second half and full year 2019 financial results
Dec 30, 2019: Auris Medical announces formation of new subsidiary for development projects in tinnitus and hearing loss
Sep 04, 2019: Auris Medical announces appointment of new Chief Financial Officer
Aug 15, 2019: Auris Medical provides business update and reports first half 2019 financial results
May 23, 2019: Auris Medical Holding provides corporate update
Mar 14, 2019: Auris Medical provides business update and reports fourth quarter and full year 2018 financial results
Feb 01, 2019: Auris Medical announces full repayment of Hercules loan facility
Jan 29, 2019: Auris Medical to Redomicile Holding Company from Switzerland to Bermuda
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List Of Tables
Auris Medical Holding Ltd, Key Facts
Auris Medical Holding Ltd, Key Employees
Auris Medical Holding Ltd, Key Employee Biographies
Auris Medical Holding Ltd, Major Products and Services
Auris Medical Holding Ltd, History
Auris Medical Holding Ltd, Subsidiaries
Auris Medical Holding Ltd, Key Competitors
Auris Medical Holding Ltd, Ratios based on current share price
Auris Medical Holding Ltd, Annual Ratios
Auris Medical Holding Ltd, Annual Ratios (Cont...1)
Auris Medical Holding Ltd, Interim Ratios
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Auris Medical Holding Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List Of Figures
Auris Medical Holding Ltd, Performance Chart (2015 - 2019)
Auris Medical Holding Ltd, Ratio Charts
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
RELATED REPORTS
Xtant Medical Holdings Inc (XTNT) - Medical Equipment - Deals and Alliances Profile.
Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The companys products include 3Demin, osteosponge,
View ReportXtant Medical Holdings Inc (XTNT) - Product Pipeline Analysis, 2017 Update
Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The companys products include 3Demin, osteosponge,
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
